Implementation of a Myasthenia Gravis Drug-Disease Interaction Clinical Decision Support Tool Reduces Prescribing of High-Risk Medications.

Implementation of a myasthenia gravis drug-disease interaction alert reduced overall patient exposure to potentially harmful medications by approximately 19%. Future optimization includes enhanced provider and pharmacist education. Further refinement of alert logic criteria to optimize medication risk reduction and reduce alert fatigue is warranted to support clinicians in prescribing and reduce electronic health record time burden.